Ophthalmic antibiotic
Showing 1 - 25 of 4,290
Nasal and Pharyngeal Microbiome Trial in Vienna (Gentamicin Ophthalmic, Ciprofloxacin Ophthalmic, Povidone Ophthalmic)
Recruiting
- Nasal and Pharyngeal Microbiome
- Gentamicin Ophthalmic
- +3 more
-
Vienna, AustriaDepartment of Clinical Pharmacology, Medical University of Vienn
Mar 10, 2022
Blepharitis Trial in United States (ISV-502 (1.0% azithromycin and 0.1% dexamethasone combined), Azasite, Dexamethasone)
Completed
- Blepharitis
- ISV-502 (1.0% azithromycin and 0.1% dexamethasone combined)
- +3 more
-
Chandler, Arizona
- +44 more
Nov 18, 2021
Cataract Senile, Endophthalmitis, Antibiotic Side Effect Trial in Makati City (Levofloxacin Ophthalmic, Moxifloxacin Ophthalmic)
Completed
- Cataract Senile
- +3 more
- Levofloxacin Ophthalmic
- Moxifloxacin Ophthalmic
-
Makati City, MM, PhilippinesPeregrine Eye and Laser Instittute
May 21, 2020
Cataract Trial in Mount Pleasant (Pred-Gati-Brom, Prednisolone acetate 1% ophthalmic suspension, Gatifloxacin Ophthalmic)
Completed
- Cataract
- Pred-Gati-Brom
- +3 more
-
Mount Pleasant, South CarolinaCarolina Eyecare Physicians, LLC
Jun 9, 2022
Myopia, Astigmatism Trial in Lackland Air Force Base (WaveLight EX500 Excimer Laser System, VisuMax Surgical Laser)
Not yet recruiting
- Myopia
- Astigmatism
- WaveLight EX500 Excimer Laser System
- VisuMax Surgical Laser
-
Lackland Air Force Base, TexasWilford Hall Ambulatory Surgical Center
May 3, 2023
Cornea Ulcer Trial in Cairo (Autologous platelet-rich plasma (PRP) eye drops)
Completed
- Cornea Ulcer
- Autologous platelet-rich plasma (PRP) eye drops
-
Cairo, EgyptAl-Azhar University
Aug 23, 2022
Endophthalmitis Trial in Paris (Pharmacokinetic and pharmacodynamic study of antibiotics used in severe endophthalmitis from
Active, not recruiting
- Endophthalmitis
- Pharmacokinetic and pharmacodynamic study of antibiotics used in severe endophthalmitis from samples taken from treated patients
-
Paris, Ile-de-France, FranceGroupe Hospitalier Paris Saint Joseph
Oct 31, 2022
Retina Disease, Retinopathy of Prematurity, Ranibizumab Trial in Zagazig (Ranibizumab (0.25 mg/0.025 mL))
Completed
- Retina Disease
- +2 more
- Ranibizumab (0.25 mg/0.025 mL)
-
Zagazig, EgyptZagazig University, Faculty of medicine
Jan 26, 2023
Keratitis, Ulcerative, Antibiotic Resistance, Microbial, Photothermal Therapy Trial in Hangzhou (Hollow gold and silver alloy
Recruiting
- Keratitis, Ulcerative
- +2 more
- Hollow gold and silver alloy cuprous oxide shell nano-shell hydrogel
- +2 more
-
Hangzhou, Zhejiang, ChinaSecond Affiliated Hospital of Zhejiang University School of Medi
Feb 24, 2022
Keratitis, Corneal Ulcer Trial in United States (PXL Platinum 330 system + Riboflavin 0.25% TE Solution, Sham CXL + Artificial
Recruiting
- Keratitis
- Corneal Ulcer
- PXL Platinum 330 system + Riboflavin 0.25% TE Solution
- Sham CXL + Artificial Tears
-
Tampa, Florida
- +7 more
Jul 13, 2022
Keratoconus, Unstable, Collagen Crosslinking, Postoperative Pain Trial in Babylon (Dextenza, Prednisolone Acetate)
Active, not recruiting
- Keratoconus, Unstable
- +2 more
- Dextenza
- Prednisolone Acetate
-
Babylon, New YorkSightMD
Jan 18, 2022
Glaucoma, Cataract Trial in Bronx (Dexamethasone Ophthalmic Insert, Prednisolone Acetate 1% Oph Susp)
Recruiting
- Glaucoma
- Cataract
- Dexamethasone Ophthalmic Insert
- Prednisolone Acetate 1% Oph Susp
-
Bronx, New YorkThe New York Eye Surgery Center
Mar 20, 2022
Endophthalmitis, Trauma, Corneal Trial in São Paulo (Intraocular Instillation Solution, Moxifloxacin Ophthalmic)
Recruiting
- Endophthalmitis
- Trauma, Corneal
- Intraocular Instillation Solution
- Moxifloxacin Ophthalmic
-
São Paulo, SP, BrazilDept of Ophthalmology - UNIFESP/Hospital São Paulo
Nov 3, 2021
Open Angle Glaucoma, Ocular Hypertension Trial in Newport Beach (Travoprost Ophthalmic Topical Cream low-dose, Travoprost
Not yet recruiting
- Open Angle Glaucoma
- Ocular Hypertension
- Travoprost Ophthalmic Topical Cream low-dose
- +4 more
-
Newport Beach, CaliforniaGlaukos Clinical Study Site
Nov 22, 2023
Corneal Edema, Corneal Defect, Anterior Chamber Inflammation Trial in Los Angeles (Dextenza 0.4Mg Ophthalmic Insert,
Not yet recruiting
- Corneal Edema
- +6 more
- Dextenza 0.4Mg Ophthalmic Insert
- +3 more
-
Los Angeles, CaliforniaAdvanced Vision Care
Dec 5, 2022
Antimicrobial Regimens in Microbial Keratitis: A Prospective
Recruiting
- Bacterial Keratitis
- +3 more
- Moxifloxacin Ophthalmic 0.5% Ophthalmic Solution
- +7 more
-
Alexandria, EgyptCornea Outpatient Clinic at Alexandria Main University Hospital
Dec 15, 2022
Cataract Surgery Trial in Montreal (Dropless Therapy, Usual Care)
Terminated
- Cataract Surgery
- Dropless Therapy
- Usual Care
-
Montreal, Quebec, Canada
- +1 more
Sep 14, 2021
Rhegmatogenous Retinal Detachment Trial in Boston (Pars plana vitrectomy, Triamcinolone Acetonide 40mg/mL, Moxifloxacin 0.5% or
Recruiting
- Rhegmatogenous Retinal Detachment
- Pars plana vitrectomy
- +4 more
-
Boston, MassachusettsMassachusetts Eye and Ear
Jul 26, 2022
Acanthamoeba Keratitis, Fungal Keratitis Trial in Madurai (Moxifloxacin Ophthalmic, Chlorhexidine Gluconate, Natamycin)
Recruiting
- Acanthamoeba Keratitis
- Fungal Keratitis
- Moxifloxacin Ophthalmic
- +4 more
-
Madurai, Tamil Nadu, IndiaAravind Eye Care System
Jan 8, 2023
Dry Eye Trial in Birmingham (Amniotic membrane Omnigen[TM], Bandage soft Contact Lens OmniLenz[R])
Recruiting
- Dry Eye
- Amniotic membrane Omnigen[TM]
- Bandage soft Contact Lens OmniLenz[R]
-
Birmingham, West Midlands, United KingdomAston University
Jul 25, 2022
Primary Open Angle Glaucoma, Ocular Hypertension Trial in Glendale, Newport Beach, Cranberry Township (SBI-100 Ophthalmic
Recruiting
- Primary Open Angle Glaucoma
- Ocular Hypertension
- SBI-100 Ophthalmic Emulsion, 0.5%
- +2 more
-
Glendale, California
- +2 more
Nov 17, 2023
Vitreoretinopathy, Coats' Disease, Exudative Retinopathy Trial in Durham (Dextenza 0.4Mg Ophthalmic Insert, Pred Forte)
Not yet recruiting
- Vitreoretinopathy
- +8 more
- Dextenza 0.4Mg Ophthalmic Insert
- Pred Forte
-
Durham, North CarolinaDuke Eye Center
Nov 10, 2022
Dry Eye Disease Trial in Bellaire (Topical spironolactone ophthalmic solution, 0.005 mg/cc, Placebo)
Not yet recruiting
- Dry Eye Disease
- Topical spironolactone ophthalmic solution, 0.005 mg/cc
- Placebo
-
Bellaire, TexasRichard W Yee, MD PLLC
Aug 16, 2023
Glaucoma, Open-Angle, Hypertension, Ocular Trial in Austin (NCX 470, Latanoprost 0.005%)
Completed
- Glaucoma, Open-Angle
- Hypertension, Ocular
- NCX 470
- Latanoprost 0.005%
-
Austin, TexasTexan Eye
Nov 9, 2022
Urinary Tract Infections Trial in Nantes (Dissemination of a selective reporting for antibiotic susceptibility testing, Standard
Not yet recruiting
- Urinary Tract Infections
- Dissemination of a selective reporting for antibiotic susceptibility testing
- Standard antibiotic susceptibility testing report
-
Nantes, FranceUniversity Hospital
Sep 28, 2023